STOCK TITAN

Sculptor discloses 7.39% Sotera Health (SHC) ownership stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Sculptor Capital entities report a 7.39% passive stake in Sotera Health Company common stock. They collectively beneficially own 21,000,000 shares of Sotera’s common stock, based on 284,093,929 shares outstanding referenced from the issuer’s 10-Q. The shares are held across various investment accounts managed by Sculptor Capital LP and Sculptor Capital II LP, with related holding and parent entities also listed as beneficial owners. The filers certify the securities are not held to change or influence control of Sotera Health, but as a passive investment under Schedule 13G.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Capital LP ("Sculptor"), a Delaware limited partnership, is the principal investment manager to a number of private funds and discretionary accounts (collectively, the "Accounts").


SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Capital II LP ("Sculptor-II"), a Delaware limited partnership that is wholly owned by Sculptor, also serves as the investment manager to certain of the Accounts. The Ordinary Shares reported in this Schedule 13G are held in the Account(s) managed by Sculptor and Sculptor-II.


SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Capital Holding Corporation ("SCHC"), a Delaware corporation, serves as the general partner of Sculptor.


SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Capital Holding II LLC ("SCHC-II"), a Delaware limited liability company that is wholly owned by Sculptor, serves as the general partner of Sculptor-II.


SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Capital Management, Inc. ("SCU"), a Delaware limited liability company, is a holding company that is the sole shareholder of SCHC and the ultimate parent company of Sculptor and Sculptor-II.


SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Master Fund, Ltd. ("SCMF") is a Cayman Islands company. Sculptor is the investment adviser to SCMF.


SCHEDULE 13G



Sculptor Capital LP
Signature:/s/ Ellen Conti
Name/Title:Ellen Conti / Chief Financial Officer
Date:02/13/2026
Sculptor Capital II LP
Signature:/s/ Ellen Conti
Name/Title:Ellen Conti / Chief Financial Officer
Date:02/13/2026
Sculptor Capital Holding Corp
Signature:/s/ Ellen Conti
Name/Title:Ellen Conti / Chief Financial Officer
Date:02/13/2026
Sculptor Capital Holding II LLC
Signature:/s/ Ellen Conti
Name/Title:Ellen Conti / Chief Financial Officer
Date:02/13/2026
Sculptor Capital Management, Inc.
Signature:/s/ Ellen Conti
Name/Title:Ellen Conti / Chief Financial Officer
Date:02/13/2026
Sculptor Master Fund, Ltd.
Signature:/s/ Ellen Conti
Name/Title:Ellen Conti / Chief Financial Officer
Date:02/13/2026

FAQ

What stake in Sotera Health (SHC) does Sculptor Capital report in this Schedule 13G/A?

Sculptor Capital entities report beneficial ownership of 21,000,000 Sotera Health common shares, representing 7.39% of the outstanding class. This percentage is calculated using 284,093,929 common shares outstanding, as disclosed in Sotera Health’s 10-Q filed on November 4, 2025.

Which Sculptor entities are listed as reporting persons for Sotera Health (SHC)?

The filing lists Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc., and Sculptor Master Fund, Ltd. Each is shown with shared voting and dispositive power over 21,000,000 Sotera Health common shares.

Is Sculptor’s Sotera Health (SHC) position reported as a passive investment?

Yes. The certification states the securities “were not acquired and are not held for the purpose of or with the effect of changing or influencing the control” of Sotera Health. They are reported under Schedule 13G as a passive ownership position, not for control transactions.

As of what date is Sculptor’s Sotera Health (SHC) ownership reported in this filing?

The Schedule 13G/A reports Sculptor’s beneficial ownership as of December 31, 2025, identified as the date of the event requiring the filing. The percentage ownership uses the share count from Sotera Health’s Form 10-Q filed on November 4, 2025.

How much voting and dispositive power does Sculptor report over Sotera Health (SHC) shares?

Each reporting entity indicates 0 shares with sole voting or dispositive power and 21,000,000 shares with shared voting and shared dispositive power. This means decisions over these shares are exercised jointly under Sculptor-managed accounts rather than individually.

Who signed the Sotera Health (SHC) Schedule 13G/A on behalf of the reporting persons?

The ownership statement is signed multiple times by Ellen Conti, Chief Financial Officer, dated February 13, 2026. The repeated signatures indicate execution on behalf of the various Sculptor-related reporting entities named in the filing.
Sotera Health Co

NASDAQ:SHC

SHC Rankings

SHC Latest News

SHC Latest SEC Filings

SHC Stock Data

4.82B
220.60M
2.46%
89.45%
3.99%
Diagnostics & Research
Services-misc Health & Allied Services, Nec
Link
United States
BROADVIEW HEIGHTS